Developing new drugs for hearing disorders
Drug Discovery and Delivery Core
This study is working on developing new and better medications for hearing problems, and it's for anyone who struggles with these issues, as well as for future researchers who want to help in this important area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Creighton University NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11061762 on NIH RePORTER |
What this research studies
This research focuses on creating effective medications for auditory disorders, which are often overlooked in medical research. The Drug Discovery & Delivery Core (DDDC) at Creighton University aims to establish a comprehensive drug development pipeline that includes advanced screening methods to identify potential new therapies. By collaborating with various research leaders and institutions, the DDDC will also optimize drug compounds and improve delivery methods to ensure they work effectively in the body. This initiative not only seeks to advance treatment options but also aims to train the next generation of researchers in this critical field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing auditory disorders, including hearing loss or other related conditions.
Not a fit: Patients with auditory disorders that are not amenable to pharmacological intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for individuals suffering from auditory disorders.
How similar studies have performed: While there is limited research specifically targeting auditory disorders, similar drug discovery approaches have shown promise in other fields, indicating potential for success in this area.
Where this research is happening
Omaha, United States
- Creighton University — Omaha, United States (Active)
Researchers
- Principal investigator: Zuo, Jian — Creighton University
- Study coordinator: Zuo, Jian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.